Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Rapid evolution may have helped bats avoid cancer, study finds
The researchers sequenced the genomes of the Jamaican fruit bat (pictured) and the Mesoamerican mustached bat.

It may also help them tolerate viruses.
 

A study has suggested that rapid evolution may be the reason why bats are able to avoid cancer, and also tolerate viral infections like SARS-CoV-2.

The researchers aimed to investigate bats’ low cancer rates and robust immune system, with the theory that it may have implications for human health. For example, performing comparative genomic analysis of bats against mammals that are susceptible to cancer may lead to new discoveries on the causes of cancer, and its links with immunity.

It could also further our understanding of why bats are tolerant to zoonotic viruses, such as SARS-CoV-2, before they get passed onto humans. This could lead to work that may better prevent disease outbreaks from animals to people.

The investigation involved the researchers using the Oxford Nanopores Technologies long-read platform to sequence the genomes of two bat species, the Jamaican fruit bat and the Mesoamerican mustached bat, which have key evolutionary positions.

They then conducted a comparative genomic analysis with a diverse collection of bats and other mammals.

This found genetic adaptations in six DNA repair-related proteins and 46 proteins in bats that were cancer-related. It revealed that these altered cancer-related genes were twice as enriched in the bats compared to other mammals.

The analysis identified antiviral genes that showed evidence of rapid evolution. There were also positive selection signs in 33 tumour suppressors and 6 DNA-repair genes which may contribute to bats’ increased longevity and reduced cancer rates.

This shows that the immune systems of bats rely on bat-wide and lineage-specific evolution among their genes, which suggests diverse immune strategies.

Armin Scheben, the lead author, said: “By generating these new bat genomes and comparing them to other mammals we continue to find extraordinary new adaptations in antiviral and anticancer genes,

“These investigations are the first step towards translating research on the unique biology of bats into insights relevant to understanding and treating aging and diseases, such as cancer, in humans.”

The full study can be found in the Genome Biology and Evolution journal.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.